PURPOSE To assess the attitude towards ovarian tissue and oocyte cryopreservation for non-medical reasons. METHODS Cross-sectional electronic survey in 248 Swiss women aged 15-35 years, nationally representative for educational level. RESULTS Most women did not worry about an age-related fertility decline. Two-thirds of women would consider using hormone therapy (HT) for menopausal symptom relief although concerns about side effects and risks were still high. Acceptance of cryopreservation of oocytes (19%) or ovarian tissue (13%) for postponing fertility or menopause was generally low, but increased (37%) if both goals could be achieved with one surgery. Cryopreservation of ovarian tissue for postponing menopause was acceptab...
The age of first pregnancies for women has been on the rise, partly due to prioritization of career ...
SummaryBackgroundOvarian tissue cryopreservation with later reimplantation has been shown to preserv...
Introduction. The aim of this study is to report the current status of ovarian tissue cryopreservati...
STUDY QUESTION Do the benefits of ovarian tissue cryopreservation outweigh the risks for patients se...
INTRODUCTION Current fertility preservation options available to women are oocyte cryopreservatio...
Oocytes can be effectively cryopreserved and stored for future use in in-vitro fertilisation. Oocyte...
STUDY QUESTION What knowledge, attitudes and intentions do US obstetrics and gynecology (OB/GYN) res...
Context: Women worldwide are delaying childbearing, but are they aware of the age-related decline in...
The optimal age to cryopreserve oocytes for later use is before 36 years. Current users are on avera...
Background: With the increasing number of young women surviving cancer and a growing trend among hig...
OBJECTIVE What are the patients attitudes about their fertility and about the counselling process...
Medical treatments at the beginning and end of human life are highly contested in public discourse. ...
This study was partly funded by the UK Medical Research Council grant G1100357 (to RAA). Open Access...
The recent introduction of oocyte vitrification has significantly advanced the outcome of oocyte cry...
peer reviewedBACKGROUND: Preservation of female fertility is a relatively new field in medicine that...
The age of first pregnancies for women has been on the rise, partly due to prioritization of career ...
SummaryBackgroundOvarian tissue cryopreservation with later reimplantation has been shown to preserv...
Introduction. The aim of this study is to report the current status of ovarian tissue cryopreservati...
STUDY QUESTION Do the benefits of ovarian tissue cryopreservation outweigh the risks for patients se...
INTRODUCTION Current fertility preservation options available to women are oocyte cryopreservatio...
Oocytes can be effectively cryopreserved and stored for future use in in-vitro fertilisation. Oocyte...
STUDY QUESTION What knowledge, attitudes and intentions do US obstetrics and gynecology (OB/GYN) res...
Context: Women worldwide are delaying childbearing, but are they aware of the age-related decline in...
The optimal age to cryopreserve oocytes for later use is before 36 years. Current users are on avera...
Background: With the increasing number of young women surviving cancer and a growing trend among hig...
OBJECTIVE What are the patients attitudes about their fertility and about the counselling process...
Medical treatments at the beginning and end of human life are highly contested in public discourse. ...
This study was partly funded by the UK Medical Research Council grant G1100357 (to RAA). Open Access...
The recent introduction of oocyte vitrification has significantly advanced the outcome of oocyte cry...
peer reviewedBACKGROUND: Preservation of female fertility is a relatively new field in medicine that...
The age of first pregnancies for women has been on the rise, partly due to prioritization of career ...
SummaryBackgroundOvarian tissue cryopreservation with later reimplantation has been shown to preserv...
Introduction. The aim of this study is to report the current status of ovarian tissue cryopreservati...